# Cinacalcet to Treat Familial Primary Hyperparathyroidism

> **NCT00325104** · PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 25 (—)

## Conditions studied

- Hypercalcemia
- Familial Primary Hyperparathyroidism

## Interventions

- **PROCEDURE:** Parathyroid hormone testing
- **PROCEDURE:** Serum calcium testing

## Key facts

- **NCT ID:** NCT00325104
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-09
- **Primary completion:** —
- **Final completion:** 2007-03-31
- **Target enrollment:** 25 (—)
- **Last updated:** 2017-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325104, "Cinacalcet to Treat Familial Primary Hyperparathyroidism". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00325104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*